BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23863837)

  • 21. Casposons: a new superfamily of self-synthesizing DNA transposons at the origin of prokaryotic CRISPR-Cas immunity.
    Krupovic M; Makarova KS; Forterre P; Prangishvili D; Koonin EV
    BMC Biol; 2014 May; 12():36. PubMed ID: 24884953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR adaptive immune systems of Archaea.
    Vestergaard G; Garrett RA; Shah SA
    RNA Biol; 2014; 11(2):156-67. PubMed ID: 24531374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-guided genetic silencing systems in bacteria and archaea.
    Wiedenheft B; Sternberg SH; Doudna JA
    Nature; 2012 Feb; 482(7385):331-8. PubMed ID: 22337052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annotation and Classification of CRISPR-Cas Systems.
    Makarova KS; Koonin EV
    Methods Mol Biol; 2015; 1311():47-75. PubMed ID: 25981466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system.
    Nam KH; Haitjema C; Liu X; Ding F; Wang H; DeLisa MP; Ke A
    Structure; 2012 Sep; 20(9):1574-84. PubMed ID: 22841292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
    Cooper EL; Overstreet N
    Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative analysis of clustered regularly interspaced short palindromic repeats (CRISPRs) loci in the genomes of halophilic archaea].
    Zhang F; Zhang B; Xiang H; Hu S
    Wei Sheng Wu Xue Bao; 2009 Nov; 49(11):1445-53. PubMed ID: 20112671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Reverse Transcriptases Associated with CRISPR-Cas Systems.
    Toro N; Martínez-Abarca F; González-Delgado A
    Sci Rep; 2017 Aug; 7(1):7089. PubMed ID: 28769116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varieties of RNase P: a nomenclature problem?
    Altman S; Gopalan V; Vioque A
    RNA; 2000 Dec; 6(12):1689-94. PubMed ID: 11142368
    [No Abstract]   [Full Text] [Related]  

  • 31. The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.
    Westra ER; van Houte S; Gandon S; Whitaker R
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20190101. PubMed ID: 30905294
    [No Abstract]   [Full Text] [Related]  

  • 32. Diverse CRISPRs evolving in human microbiomes.
    Rho M; Wu YW; Tang H; Doak TG; Ye Y
    PLoS Genet; 2012; 8(6):e1002441. PubMed ID: 22719260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origins and evolution of CRISPR-Cas systems.
    Koonin EV; Makarova KS
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180087. PubMed ID: 30905284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
    Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
    RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CRISPR system: small RNA-guided defense in bacteria and archaea.
    Karginov FV; Hannon GJ
    Mol Cell; 2010 Jan; 37(1):7-19. PubMed ID: 20129051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing leader sequences of CRISPR loci.
    Alkhnbashi OS; Shah SA; Garrett RA; Saunders SJ; Costa F; Backofen R
    Bioinformatics; 2016 Sep; 32(17):i576-i585. PubMed ID: 27587677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
    Charpentier E; Richter H; van der Oost J; White MF
    FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.